HONORHEALTH SCOTTSDALE SHEA MED CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $18.7M
- Transactions
- 1,948
- Companies
- 40
- Average per transaction
- $9,591
Who reported the payments
| Merck | $3,134,887 |
| Pfizer | $3,028,974 |
| Deciphera Pharmaceuticals Inc. | $1,845,036 |
| Corcept Therapeutics | $1,681,126 |
| Bristol Myers Squibb | $930,363 |
| CSL Behring | $893,267 |
| Genentech, Inc. | $862,261 |
| Plexxikon Inc. | $809,924 |
| Amgen | $625,385 |
| Rhythm Pharmaceuticals, Inc. | $524,108 |
| Siemens Medical Solutions USA, Inc. | $348,014 |
| Boston Scientific | $327,772 |
| AbbVie | $279,309 |
| Jazz Pharmaceuticals Inc. | $251,274 |
| Tesaro, Inc. | $222,398 |
| Gilead | $160,044 |
| Janssen Research & Development, LLC | $156,625 |
| Adamas Pharmaceuticals, Inc. | $151,978 |
| Redhill Biopharma Inc. | $140,748 |
| Incyte Corporation | $134,752 |
| Eli Lilly | $130,333 |
| Ares Trading SA | $121,070 |
| Galvanize Therapeutics, Inc | $116,472 |
| F. Hoffmann-la Roche AG | $113,515 |
| EMD Serono, Inc. | $112,765 |
| Argenx US, Inc. | $108,343 |
| Mitsubishi Tanabe Pharma Development America, Inc. | $102,468 |
| Blueprint Medicines Corporation | $98,567 |
| Syndax Pharmaceuticals, Inc. | $98,448 |
| Biontech SE | $95,610 |
| Astellas Pharma Global Development | $94,786 |
| Takeda Pharmaceuticals U.S.A., Inc. | $93,543 |
| E.r. Squibb & Sons, L.L.C. | $93,458 |
| AstraZeneca | $85,524 |
| Cardiofocus, Inc. | $64,991 |
| Medivation LLC. | $64,700 |
| Livanova USA, Inc. | $61,483 |
| Gynesonics, Inc. | $51,827 |
| Institut DE Recherches Servier | $48,608 |
| Zimmer Biomet | $48,413 |